Hosted on MSN1mon
WuXi Biologics to sell Ireland-based vaccine site to MSD for $500mWuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback